search
Back to results

Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) ) (SERRE)

Primary Purpose

Femoral Fracture

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Implantation of Ortholoop cerclage
Implantation of Cerclage used in current practice
Sponsored by
Quanta Medical
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Femoral Fracture

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patient with femoral or humeral fracture requiring the installation of one or more cerclage(s) and respecting at least one of the criteria below:
  • Primary femoral or humeral fractures (diaphyseal, metaphyseal, epiphyseal proximal or distal) with osteosynthesis by plate and screw or osteosynthesis by Intramedullary nailing associated with the installation of one or more cerclage(s)
  • Patients with traumatic fracture of femur or humerus that required prosthetic rehabilitation associated with the installation of one or more cerclage(s)
  • Peri-prosthetic fracture of the femur or humerus
  • Resumption of prosthesis (hip, knee, shoulder, elbow) requiring the installation of one or more cerclages
  • who underwent fixation with cerclage wiring (Sterile Self Locking Polymer Cerclage System or other cerclage systems used in standard care)
  • age ≥18 years
  • Who have given free, informed and written consent to participate in the study
  • Patient able to communicate in French
  • Patient affiliated to a social security system or entitled to a social security system

Exclusion Criteria:

  • high-energy injury,
  • associated damage to other long bones,
  • fracture extension to the articular surface with displacement
  • Severe disease that could interfere with the study results or be life threatening
  • Patients with an infection
  • Allergy to any component of the medical products
  • Pregnant or breastfeeding women
  • Anticipated unavailability during the study
  • Participation in a clinical trial within 3 months prior to the inclusion visit.
  • Patient with linguistic or psychological incapacity to understand and sign the informed consent.
  • Patient deprived of liberty by administrative or judicial decision, or being under guardianship.

Sites / Locations

  • CHU LilleRecruiting
  • CH AgenRecruiting
  • CH Arcachon
  • Clinique de Saint OmerRecruiting
  • CH Le MansRecruiting
  • CH LibourneRecruiting
  • Ch Metz - ThionvilleRecruiting
  • CHRU NancyRecruiting
  • CHU Nimes
  • Polyclinique Du ParcRecruiting
  • CHU Toulouse
  • CH ValenciennesRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Polymer Cerclage System OrthoLoop

cerclages used in standard care

Arm Description

Patients receives Ortholoop Cerclage System

Patients receives cerclages used in standard care"

Outcomes

Primary Outcome Measures

Assess role of Polymer Cerclage System OrthoLoop of COUSIN Biotech in comparison with cerclages (metallic for the majority) used in standard care; in the optimization of the consolidation of primary and periprosthetic fractures of long bones
primary endpoint will be success or failure 6 months after surgery: Success of "Sterile Self Locking Polymer Cerclage System" to optimize consolidation during 6 months post surgery is defined as: the ability to walk full weight bearing without pain at the fracture site, or return to normal, painless mobility at the fracture site, and radiographs showing signs of bony union with no rupture or migration of the cerclage. Rupture or cerclage migration or nonunion or need for revision of the implant before 6 months is considered as failure.

Secondary Outcome Measures

Assess consolidation rate during 6 months post surgery
Consolidation (or union) is defined as the ability to walk full weight bearing without pain or return to normal, painless mobility at the fracture site , and radiographs showing signs of bony union
Asses union time
Union time is defined as time from intervention until For Femoral fracture: ability of patient to walk full weight bearing without pain at the fracture site and radiographs showing signs of bony union For humeral fracture: The patient regained full mobility without pain at the fracture site.
Assess rupture and migration rate of the cerclage after surgery throughout the follow-up
Rupture and migration of the cerclage are confirmed on X Ray imaging.
Assess pain
Pain will be assessed using visual analog scale pain scores (VAS) from 0 to 100 (0 means no pain at all and 100 maximum pain) at each visit.
To report the incidence of complications and their treatment, particularly with respect to the need of further surgery
Safety data during patients 36 months follow up are defined such as: Infection Neurovascular injury Allergic reaction Bone ischemia Irritation feeling
Assess surgery characteristics
Surgery characteristics are: Rupture of cerclage during the surgery (at time of implantation) Number of wire cerclages used implant used for osteosynthesis (nail or plate) Using of screw fixation operative time
Assess physicians satisfaction regarding the use of "Sterile Self Locking Polymer Cerclage System
Physicians satisfaction regarding the use of "Sterile Self Locking Polymer Cerclage System" will be assessed on: Global satisfaction of the surgeon Ease of use Ancillaries (Cable Passer, Tensioner) : ease of use and lightweight Ease of tension control by the surgeon using tensioner Ease of tracking of the cerclage on radiography Resistance over time (at least until bone consolidation) Presentation (ease of unwinding, packaging)

Full Information

First Posted
September 21, 2021
Last Updated
September 13, 2022
Sponsor
Quanta Medical
Collaborators
Cousin Biotech
search

1. Study Identification

Unique Protocol Identification Number
NCT05087667
Brief Title
Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )
Acronym
SERRE
Official Title
Outcomes of Adjuvant "Polymer Cerclage System "OrthoLoop" to Manage Prosthetic Rehabilitation, Per Prosthetic or Primary Femoral and Humeral Fractures. A Prospective , Multicentric, Simple Blind , Comparative, Non-inferiority Study, Compared to Cerclage Systems Used in Standard Care.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 8, 2022 (Actual)
Primary Completion Date
October 2023 (Anticipated)
Study Completion Date
October 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Quanta Medical
Collaborators
Cousin Biotech

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The use of cerclage wiring in the management of long bone fractures is common. With the increase in the placement of total hip ans shoulder prostheses, the occurrence of peri-prosthetic hip an shoulder fractures is also increasing, notably due to an older population. Whether it is for a fracture on a native femur or humerus, or on a periprosthetic hip or shoulder fracture, the use of cerclage wiring is an adjuvant additional but not the main means to ensure stable osteosynthesis, allowing re-loading and early rehabilitation of patients. This method has demonstrated its ability to improve the fixation of this fracture type, associated with osteosynthesis or hip/shoulder prosthesis revision surgery. However, metal cerclage expose to a risk of metallosis which can compromise bone fusion, injury to neighboring soft parts causing pain and also injury to the surgical team when handling them. More recently, non-metallic cerclage have been developed and could overcome certain risks associated with metallic cerclage, while ensuring their bone fixing capacity and therefore bone consolidation. Indeed, non-metallic cerclage could withstand similar or even greater stresses than metallic cables, in particular concerning their resistance to rupture. The "Sterile Self Locking Polymer Cerclage System" named OrthoLoop is a polymer cerclage which has been developed and could be used in these indications. Thus, this study (SERRE) aims to investigate the clinical results and sequelae of adjuvant cerclage wires OrthoLoop Cerclage in the management of rehabilitation, per prosthetic or primary femoral or humeral fractures compared with cerclages system used in standard care. SERRE is a 36 months follow up study in two arms : Experimental group: "OrthoLoop cercalge" Control group: "cerclages used in standard care" After each surgery, the patient follow-up period is 36 months. with 4 planned consultation visits after surgery at 6-8 weeks, 3, 6 and 36 months, with collection and measurement of the endpoints. The main objective of this study is to assess the role of "OrthoLoop cerclage" of COUSIN Biotech in comparison with cerclages (metallic for the majority) used in standard care ; in the optimization of the consolidation of primary and periprosthetic femoral or humeral fractures, 6 months after surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Femoral Fracture

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Cluster's randomization
Masking
Participant
Masking Description
Single blinded study. The patient will be blinded from the randomization arm. As the procedure is performed under general anaesthesia, the patient will not be informed whether or not the Sterile Self Locking Polymer Cerclage System has been implanted as a result of the procedure.
Allocation
Randomized
Enrollment
194 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Polymer Cerclage System OrthoLoop
Arm Type
Experimental
Arm Description
Patients receives Ortholoop Cerclage System
Arm Title
cerclages used in standard care
Arm Type
Active Comparator
Arm Description
Patients receives cerclages used in standard care"
Intervention Type
Device
Intervention Name(s)
Implantation of Ortholoop cerclage
Intervention Description
implantation of Sterile Self Locking Polymer Cerclage System named OrthoLoop to the patient and follow up for 36 months post-intervention
Intervention Type
Device
Intervention Name(s)
Implantation of Cerclage used in current practice
Intervention Description
implantation of Cerclage used in current practice to patients and follow up for 36 months post-intervention
Primary Outcome Measure Information:
Title
Assess role of Polymer Cerclage System OrthoLoop of COUSIN Biotech in comparison with cerclages (metallic for the majority) used in standard care; in the optimization of the consolidation of primary and periprosthetic fractures of long bones
Description
primary endpoint will be success or failure 6 months after surgery: Success of "Sterile Self Locking Polymer Cerclage System" to optimize consolidation during 6 months post surgery is defined as: the ability to walk full weight bearing without pain at the fracture site, or return to normal, painless mobility at the fracture site, and radiographs showing signs of bony union with no rupture or migration of the cerclage. Rupture or cerclage migration or nonunion or need for revision of the implant before 6 months is considered as failure.
Time Frame
6 months post-surgery
Secondary Outcome Measure Information:
Title
Assess consolidation rate during 6 months post surgery
Description
Consolidation (or union) is defined as the ability to walk full weight bearing without pain or return to normal, painless mobility at the fracture site , and radiographs showing signs of bony union
Time Frame
6 months post-surgery
Title
Asses union time
Description
Union time is defined as time from intervention until For Femoral fracture: ability of patient to walk full weight bearing without pain at the fracture site and radiographs showing signs of bony union For humeral fracture: The patient regained full mobility without pain at the fracture site.
Time Frame
3, 6 and 36 months post-surgery
Title
Assess rupture and migration rate of the cerclage after surgery throughout the follow-up
Description
Rupture and migration of the cerclage are confirmed on X Ray imaging.
Time Frame
3, 6 and 36 months post-surgery
Title
Assess pain
Description
Pain will be assessed using visual analog scale pain scores (VAS) from 0 to 100 (0 means no pain at all and 100 maximum pain) at each visit.
Time Frame
6-8 weeks,3, 6 and 36 months post-surgery
Title
To report the incidence of complications and their treatment, particularly with respect to the need of further surgery
Description
Safety data during patients 36 months follow up are defined such as: Infection Neurovascular injury Allergic reaction Bone ischemia Irritation feeling
Time Frame
During the whole study (up to 36 months)]
Title
Assess surgery characteristics
Description
Surgery characteristics are: Rupture of cerclage during the surgery (at time of implantation) Number of wire cerclages used implant used for osteosynthesis (nail or plate) Using of screw fixation operative time
Time Frame
During surgery (at D0)
Title
Assess physicians satisfaction regarding the use of "Sterile Self Locking Polymer Cerclage System
Description
Physicians satisfaction regarding the use of "Sterile Self Locking Polymer Cerclage System" will be assessed on: Global satisfaction of the surgeon Ease of use Ancillaries (Cable Passer, Tensioner) : ease of use and lightweight Ease of tension control by the surgeon using tensioner Ease of tracking of the cerclage on radiography Resistance over time (at least until bone consolidation) Presentation (ease of unwinding, packaging)
Time Frame
During surgery (at D0)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patient with femoral or humeral fracture requiring the installation of one or more cerclage(s) and respecting at least one of the criteria below: Primary femoral or humeral fractures (diaphyseal, metaphyseal, epiphyseal proximal or distal) with osteosynthesis by plate and screw or osteosynthesis by Intramedullary nailing associated with the installation of one or more cerclage(s) Patients with traumatic fracture of femur or humerus that required prosthetic rehabilitation associated with the installation of one or more cerclage(s) Peri-prosthetic fracture of the femur or humerus Resumption of prosthesis (hip, knee, shoulder, elbow) requiring the installation of one or more cerclages who underwent fixation with cerclage wiring (Sterile Self Locking Polymer Cerclage System or other cerclage systems used in standard care) age ≥18 years Who have given free, informed and written consent to participate in the study Patient able to communicate in French Patient affiliated to a social security system or entitled to a social security system Exclusion Criteria: high-energy injury, associated damage to other long bones, fracture extension to the articular surface with displacement Severe disease that could interfere with the study results or be life threatening Patients with an infection Allergy to any component of the medical products Pregnant or breastfeeding women Anticipated unavailability during the study Participation in a clinical trial within 3 months prior to the inclusion visit. Patient with linguistic or psychological incapacity to understand and sign the informed consent. Patient deprived of liberty by administrative or judicial decision, or being under guardianship.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marc Saab, Dr
Phone
+33 (0) 1 47 08 63 41
Email
b.hill@quanta-medical.com
Facility Information:
Facility Name
CHU Lille
City
Lille
State/Province
Nord
ZIP/Postal Code
59000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marc SAAB
Email
Marc.SAAB@CHRU-LILLE.FR
Facility Name
CH Agen
City
Agen
ZIP/Postal Code
47000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adrian BACIULESCU, Dr
Phone
0623900370
Email
baciulescua@ch-agen-nerac.fr
Facility Name
CH Arcachon
City
Arcachon
ZIP/Postal Code
33164
Country
France
Individual Site Status
Active, not recruiting
Facility Name
Clinique de Saint Omer
City
Blendecques
ZIP/Postal Code
62575
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pierre-Emmanuel RIDON, Dr
Phone
06 67 53 77 94
Email
pierre.emmanuel.ridon@gmail.com
Facility Name
CH Le Mans
City
Le Mans
ZIP/Postal Code
72037
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lilian COZMA, Dr
Phone
06 30 11 26 86
Email
lcozma@ch-lemans.fr
Facility Name
CH Libourne
City
Libourne
ZIP/Postal Code
33505
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pierre MEYNARD, Dr
Phone
06 74 77 66 19
Email
pierre.meynard@ch-libourne.fr
Facility Name
Ch Metz - Thionville
City
Metz
ZIP/Postal Code
57085
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
MBarek IRRAZI, Dr
Phone
06 62 62 51 38
Email
Mb.irrazi@chr-metz-thionville.fr
Facility Name
CHRU Nancy
City
Nancy
ZIP/Postal Code
54000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Didier MAINARD, Pr
Phone
03 83 85 17 82
Email
didier.mainard@univ-lorraine.fr
Facility Name
CHU Nimes
City
Nîmes
ZIP/Postal Code
30900
Country
France
Individual Site Status
Active, not recruiting
Facility Name
Polyclinique Du Parc
City
Saint-Saulve
ZIP/Postal Code
59880
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Arnaud MULLIEZ, Dr
Phone
03 27 23 92 79
Email
amulliez@cliniqueduparc.com
Facility Name
CHU Toulouse
City
Toulouse
ZIP/Postal Code
31300
Country
France
Individual Site Status
Active, not recruiting
Facility Name
CH Valenciennes
City
Valenciennes
ZIP/Postal Code
59300
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maciej SMOCZINSKY, Dr
Phone
06 32 34 31 80
Email
smoczynski-m@ch-valenciennes.fr

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
17477925
Citation
Lindahl H. Epidemiology of periprosthetic femur fracture around a total hip arthroplasty. Injury. 2007 Jun;38(6):651-4. doi: 10.1016/j.injury.2007.02.048. Epub 2007 May 2.
Results Reference
result
PubMed Identifier
21157744
Citation
Rayan F, Haddad F. Periprosthetic femoral fractures in total hip arthroplasty - a review. Hip Int. 2010 Oct-Dec;20(4):418-26. doi: 10.1177/112070001002000402.
Results Reference
result
PubMed Identifier
19462362
Citation
Tsiridis E, Pavlou G, Venkatesh R, Bobak P, Gie G. Periprosthetic femoral fractures around hip arthroplasty: current concepts in their management. Hip Int. 2009 Apr-Jun;19(2):75-86. doi: 10.1177/112070000901900201.
Results Reference
result
PubMed Identifier
31096789
Citation
Ferbert T, Jaber A, Gress N, Schmidmaier G, Gotterbarm T, Merle C. Impact of intraoperative femoral fractures in primary hip arthroplasty: a comparative study with a mid-term follow-up. Hip Int. 2020 Sep;30(5):544-551. doi: 10.1177/1120700019849911. Epub 2019 May 17.
Results Reference
result
PubMed Identifier
24002835
Citation
Ebraheim NA, Sochacki KR, Liu X, Hirschfeld AG, Liu J. Locking plate fixation of periprosthetic femur fractures with and without cerclage wires. Orthop Surg. 2013 Aug;5(3):183-7. doi: 10.1111/os.12052.
Results Reference
result
PubMed Identifier
26983607
Citation
Angelini A, Battiato C. Combination of low-contact cerclage wiring and osteosynthesis in the treatment of femoral fractures. Eur J Orthop Surg Traumatol. 2016 May;26(4):397-406. doi: 10.1007/s00590-016-1761-3. Epub 2016 Mar 17.
Results Reference
result
PubMed Identifier
27338228
Citation
Gordon K, Winkler M, Hofstadter T, Dorn U, Augat P. Managing Vancouver B1 fractures by cerclage system compared to locking plate fixation - a biomechanical study. Injury. 2016 Jun;47 Suppl 2:S51-7. doi: 10.1016/S0020-1383(16)47009-9.
Results Reference
result
PubMed Identifier
25186972
Citation
Angelini A, Battiato C. Past and present of the use of cerclage wires in orthopedics. Eur J Orthop Surg Traumatol. 2015 May;25(4):623-35. doi: 10.1007/s00590-014-1520-2. Epub 2014 Sep 4.
Results Reference
result
PubMed Identifier
19571089
Citation
Altenburg AJ, Callaghan JJ, Yehyawi TM, Pedersen DR, Liu SS, Leinen JA, Dahl KA, Goetz DD, Brown TD, Johnston RC. Cemented total hip replacement cable debris and acetabular construct durability. J Bone Joint Surg Am. 2009 Jul;91(7):1664-70. doi: 10.2106/JBJS.G.00428.
Results Reference
result
PubMed Identifier
8792246
Citation
Silverton CD, Jacobs JJ, Rosenberg AG, Kull L, Conley A, Galante JO. Complications of a cable grip system. J Arthroplasty. 1996 Jun;11(4):400-4. doi: 10.1016/s0883-5403(96)80029-5.
Results Reference
result
PubMed Identifier
31326103
Citation
Peeters I, Depover A, Van Tongel A, De Wilde L. A review of metallic and non-metallic cerclage in orthopaedic surgery: Is there still a place for metallic cerclage? Injury. 2019 Oct;50(10):1627-1633. doi: 10.1016/j.injury.2019.06.034. Epub 2019 Jul 13.
Results Reference
result

Learn more about this trial

Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )

We'll reach out to this number within 24 hrs